Showing results (61-70 of 405) with videos related to

Sort By:
Pageof 41
Brain Communications|December 15, 2022
Arbaclofen extended-release tablets for spasticity in multiple sclerosis: randomized, controlled clinical trialDarin T Okuda, Daniel Kantor, Mark Jaros, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 5, 2026
Cardiovascular comorbidities are associated with cross-sectional and longitudinal measures of multiple sclerosis fatigueMahsa Ghajarzadeh, Ellen M Mowry, Kathryn C Fitzgerald, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 8, 2021
Vascular comorbidity is associated with lower brain volumes and lower neuroperformance in a large multiple sclerosis cohortKathryn C Fitzgerald, Anne Damian, Devon Conway, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 5, 2024
Association between demographics, socioeconomics, and disease-related factors and the perception of stigma in people with MSMahsa Ghajarzadeh, Kathryn C Fitzgerald, Ellen M Mowry, et al.
Annals of Indian Academy of Neurology|February 26, 2010
Management of acute exacerbations in multiple sclerosisDaniel Ontaneda, Alex D Rae-Grant
Expert Review of Neurotherapeutics|May 2, 2023
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosisAnnalisa Morgan, Emma Tallantyre, Daniel Ontaneda
Neurology. Clinical Practice|March 20, 2020
Primary CNS lymphoma initially diagnosed as vasculitisLauren Feldman, Yuebing Li, Daniel Ontaneda
Multiple Sclerosis and Related Disorders|January 6, 2024
Differentiating multiple sclerosis from non-specific white matter changes using a convolutional neural network image classification modelMoein Amin, Kunio Nakamura, Daniel Ontaneda
Seminars in Neurology|November 10, 2025
Artificial Intelligence and Multiple Sclerosis: Past, Present, and FutureMoein Amin, Kunio Nakamura, Daniel Ontaneda
Pageof 41